KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 1

The Cause and Clinical Symptoms of Cardiac Tamponade and Outcomes of Pericardiocentesis in the Black Sea Region of Turkey

Ömer GEDİKLİ
Sayfa
27–32
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our findings demonstrated that Echo-guided by 2D echocardiography is a safe and effective method of pericardiocentesis

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: We examined the patients with cardiac tamponade who underwent pericardiocentesis via 2-D Echocardiography to demonstrate etiology and symptoms.Methods: We enrolled 65 consecutive patients, older than 18 that were admitted to the emergency service with thesign of cardiac tamponade in Ondokuz Mayıs University Hospital from May 2012 to April 2020.
📊
Temel Bulgular & Veri:The cardiac tamponadehas diagnosed via clinical presentation and two-dimensional echocardiography and ıt confirmed by the clinical response after pericardiocentesis.Results: The average age was 66±15 years and 41 patients (63%) patients were female.
💡
Sonuç & Katkı:Our findings demonstrated that Echo-guided by 2D echocardiography is a safe and effective method of pericardiocentesis
🔬Tür:Araştırma Makalesi
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: We examined the patients with cardiac tamponade who underwent pericardiocentesis via 2-D Echocardiography to demonstrate etiology and symptoms.Methods: We enrolled 65 consecutive patients, older than 18 that were admitted to the emergency service with thesign of cardiac tamponade in Ondokuz Mayıs University Hospital from May 2012 to April 2020. The cardiac tamponadehas diagnosed via clinical presentation and two-dimensional echocardiography and ıt confirmed by the clinical response after pericardiocentesis.Results: The average age was 66±15 years and 41 patients (63%) patients were female. The mean heart rate 103.8±8.7bpm, systolic blood pressure (BP) was 88.4±9.7 mmHg, diastolic BP was 48.5+11mmHg, average catheter duration was3.6±0.9 days. The most common symptom of patients with cardiac tamponade was dyspnea (69%). The malignancywas the main cause of pericardial tamponade with 25 patients (38%). The 8 of patients (33%) with malignant cardiactamponade associated with Lung Cancer.Conclusion: Malignancy is the most common cause of pericardial effusion and dyspnea is the most common symptom. Our findings demonstrated that Echo-guided by 2D echocardiography is a safe and effective method of pericardiocentesis

🔖

Bu Makaleye Atıf Yap

GEDİKLİ, Ö. (2022). The Cause and Clinical Symptoms of Cardiac Tamponade and Outcomes of Pericardiocentesis in the Black Sea Region of Turkey. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 1, 27–32. https://ajindex.com/articles/508604

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Kilpatrick ZM, Chapman CB. On pericardiocentesis. Am J Cardiol 1965;16:722–8
  2. Maggiolini S, Gentile G, Farina A, De Carlini CC, Lenatti L, Meles E, et al. Safety, Efficacy, and Complications of Pericardiocentesis by Real-Time Echo-Monitored Procedure. Am J Cardiol 2016;117:1369–74
  3. Markiewicz W, Borovik R, Ecker S. Cardiac tamponade in medical patients: Treatment and prognosis in the Echocardiographic era. Am Heart 1986;111:1138–42
  4. Strobbe A, Adriaenssens T, Bennett J, Dubois C, Desmet W, McCutcheon K, Van Cleemput J, Sinnaeve PR. Etiology and LongTerm Outcome of Patients Undergoing Pericardiocentesis. J Am Heart Assoc 2017;6:e007598
  5. Turak O, Gürel M, Çagli K, Özcan F, Ekizler A, Cebeci M, et al. Pericardial effusion: etiology, diagnose and management. Duzce Med 2012;14:23–7
  6. Vayre F, Lardoux H, Pezzano M, Bourdarias JP, Dubourg O. Subxiphoid pericardiocentesis guided by contrast two-dimensional echocardiography in cardiac tamponade: experience of 110 consecutive patients. Eur J Echocardiogr 2000;1:66–71
  7. Burgess LJ. Biochemical analysis of pleural, peritoneal and pericardial effusions. Clin Chim Acta 2004;343:61–84 8. Light RW. Pleural effusion. N Engl J Med 2002;346:1971–7
  8. Colombo A, Olson HG, Egan J, Gardin JM. Etiology and prognostic implications of a large pericardial effusion in men. Clin Cardiol 1988;11:389–94
  9. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004;25:587–610
  10. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981;71:407–13
  11. Ertem AG, Aytürk M, Duran M, Özkan S, Sunman H, Kılıç H, et al. Ciddi perikardiyal efüzyonun etiyolojisi, tanısı ve yönetimi: tek merkez deneyimi dicle tıp dergisi 2014,41:629–34
  12. E A Rutsky, S G Rostand. Treatment of uremic pericarditis and pericardial effusion Am J Kidney Dis 1987;10:2–8
  13. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM 2004;97:525–35
  14. Guberman BA, Fowler NO, Engle PJ, Gueron M, Allen JM. Cardiac tamponade in medical patients. Circulation 1981;6